We need to make clear that monopoly grants come with responsibility and accountability, and that competition is more important to the public than a blank check for innovation we cannot afford. Read More
CalPERS said it spent nearly $40 million for Sovaldi on plans run by Blue Shield of California, Kaiser Permanente and CVS Health. Read More
Sophisticated drugs are opening the door, scientists say, to an era of "precision medicine." They're also ushering in an age of astronomical prices. Read More
May 21, 2015 Morning Consult: “New Cures, Old Problems: Poll Shows Drug… Read More
May 20, 2015 “Prescription drug prices climb into the stratosphere”… Read More
ICYMI – May 15, 2015 ***** The New England Journal of Medicine: “T… Read More
May 14, 2015 The House Energy and Commerce Committee released an updated… Read More
May 13, 2015 The New York Times: “Cystic Fibrosis Drug Wins Approval of… Read More
May 12, 2015 InsideHealthPolicy.com Health Reform Insider: “As E&C… Read More
May 11, 2015 The Wall Street Journal: “Vertex’s Cystic-Fibrosis… Read More
Weekly Update – 5/8/2015 We learned this week that worldwide spending on… Read More
ICYMI: May 7, 2015 PharmaExec.com: “Take a Breath” on the Specialty Drug… Read More